disorders and low protein diet, etc. With the deeper development of science and technology, much more new theories and technologies applied to DN. Because of its characteristics with various metabolic disorders, metabolomics studies appear more prominent.
Introduction
Diabetic Nephropathy (DN) refers to that various causes lead to the absolute or relative lack of insulin, resulting in glucose, protein and fat metabolism disorders, and it is a systemic disease based on main clinical manifestations of chronic high blood sugar. As one of the most common clinical diabetic complications, the incidence of DN is also on the rise in our country, and it has become the second cause of end-stage renal disease, just next to various glomerular nephritis [1] . It is also one of the major reasons for death and disability in patients with diabetes mellitus. Its mechanism is much complicated, and still not entirely clear, but it is generally believed that continuous renal hemodynamic changes caused by high blood sugar, sugar metabolic abnormalities associated with protein and fat metabolism disorder are the foundation of DN pathogenesis. Its clinical manifestations are related to the course of the disease, based on proteinuria as a prominent feature. Once the DN progressed to end-stage kidney disease, treatment is often much more difficult than other kidney disease. The current clinical treatment of DN includes reducing blood sugar and blood pressure, regulation of lipid metabolism night albuminuria test is more accurate and more meaningful [6] . Serum creatinine and glomerular filtration function are also the indicators of renal damage in patients with diabetes, but albumin often can be found until the DN in clinical phase 3 when the treatment has been very difficult. Therefore looking for more sensitive and reliable clinical index for early diagnosis and treatment of DN has been the hot point in clinical study of DN. In recent years, research about DN patients' metabolites in serum, urine and other body fluids developed rapidly which opened up a new pathway in the research of DN. The purpose of this paper is to have a comprehensive summary on the relative metabolomics research of DN and provide some new ideas about the diagnosis and treatment of DN based on metabonomics in detail.
Methods

Search strategy
Literature searches of MEDLINE (PubMed) for relevant articles were conducted up with the key term combinations of 'metabolomics'or 'metabonomics' with 'Diabetic nephropathy'. To minimize selection bias, two investigators independently reviewed titles, abstracts and available full-text articles for relevance. Additional articles were identified through searching the reference lists from included studies. Disagreements were resolved by consensus and by a third investigator (Figure 1 ).
Prespecified inclusion criteria
(1) Article is original instead of review. 
Data extraction and analysis
Data on techniques and study results were extracted. One investigator performed the data extraction, which was verified by a second investigator.
Results
The selection algorithm for the 18 studies which met the inclusion/exclusion criteria for our systematic review is detailed in Fig. 1 . These 18 articles include 11 clinical researches and 7 animal model researches with rats, mice and monkeys. Eight studies are based on NMR, three studies are on the basis of GC-MS, four studies are based on LC-MS, only one study is on the basis of CE-MS, and two studies are based on both GC-MS and LC-MS.
Metabolomic analytical technologies
Nuclear Magnetic Resonance (NMR): NMR refers to the resonance transition phenomenon between the magnetic energy level of the substance's nucleus system in a magnetic field, while the corresponding frequency electromagnetic radiation has an effect on them. High resolution NMR technology was used to detect the metabolome in complete organ or tissue cell. And then the corresponding metabolites information can be obtained to study the NMR spectrum of these metabolisms which can reflect some biological significance. It has the advantage of simple pretreatment method, short analysis time, high flux and no damage of the sample. But compared with mass spectrometry, the disadvantage is that the sensitivity and resolution is relatively low. Specific conditions of DN metabolomics are shown in Table  1 .
Gas Chromatography-Mass Spectrometry (GC-MS): It was combined utilization of gas chromatography with mass spectrometry. Gas chromatography is the use of capillary column to separate the sample according to different chemical components. After the separated molecules across the mass spectrometer, its nature can be measured. That means gas chromatographic separates the mixtures, and mass spectrometry detects molecules. It has high sensitivity to detect a large number of small molecule metabolites with low concentration. It is suitable for the qualitative analysis of the unknown component in multicomponent mixture. Most of the samples need to have the derivatization under room temperature or heating conditions. Specific conditions of DN metabolomics are shown in Table 2 .
Liquid Chromatography-Mass Spectrometry (LC-MS): LC-MS is a technology which uses liquid chromatography to separate and mass spectrometry to detect. Based on the theory of classic chromatography, High-performance liquid chromatography (HPLC) changes the mobile phase into high pressure conveying in technology, separating on the chromatographic column, and detecting by the mass spectrometer. And compared with HPLC, Ultra high performance liquid chromatography (UPLC) has more flux, high sensitivity and more chromatographic peak capacity. Specific conditions of DN metabolomics are shown in Table 3 .
Capillary Electrophoresis-Mass Spectrometry (CE-MS):
Capillary electrophoresis is a kind of new technology. Capillary channel was used to separate, and high voltage direct current as a new driving force. Its biggest advantage was the little amount sample. The separation mechanism is different from the HPLC and GC. The ionic metabolites could be separated, and different metabolites map could also be obtained at the same time using CE. Specific conditions of DN metabolomics are shown in Table 4 . 
Data analysis for metabolomics
Metabolomics data of DN is complex and diverse, the appropriate data analysis tools should be used to screen more meaningful data and get more useful information, meanwhile the metabolic processes and the related mechanism could be described better. Recently, the common methods of data analysis are PCA, PLS-DA and OPLS-DA, etc. The PCA is often used to observe the distribution of all data including the clustering and the outlier, and distinguish DN groups from control group clearly [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . The PLS-DA is performed to visualize the systemically metabolic alterations among different groups and identify the response variables contributing most to the model and further identify potential markers of DN [10, 12, 14, [17] [18] [19] . The OPLS-DA could be used to perform pattern recognition, and identify the changes of metabolites and potential biomarkers through the model analysis and nonparametric test [7, 8, 20, 21] .
Metabolomics for DN
Metabolomics in clinical research: The samples from metabolomic study of DN often concentrated in the urine, serum or plasma in clinical. Details of metabolites are shown in Table  5 . Some studies have found the significant correlations between the metabolites and the changes in urinary albumin excretion [22] or mitochondrial function [9] . These metabolites may be used as potential biomarkers for prediction of progression in DN. CE-MS-based metabolome analysis was also used to distinguish the severity of DN from non-DN, micro-DN, and macro-DN serum samples [20] . Taken together, a large number of clinical researches prove that the concentration of some differential metabolites and biomarkers have strong link with the development of DN.
It is important to note that the extent of changes in differential metabolites and biomarkers also played an important role in the studies. Investigators found that symmetric dimethylarginine (SDMA) in DN patient is a more sensitive marker than asymmetric dimethylarginine (ADMA), because ADMA was under the detection limit, but SDMA was positively correlated with a decrease in function of kidney [20] . And some researches indicated that the NEFAs' concentration shows little changes and the EFAs' levels increase from the stage of DM to the stage of DNIII [18] .
In addition, several metabolic pathways were identified from metabolomics studies. Metabolites from the Krebs cycle, pyrimidine metabolism, amino acid, propionate, fatty acid, and oxalate metabolism were all significantly reduced in the urine of patients with diabetic kidney disease [9] . Investigators found significant accumulation of urea cycle intermediates in the patients with end-stage renal disease [20] . Glucosylceramide formation represented an important pathway for glucose metabolism in diabetic nephropathy [13] . And the purine and pyrimidine metabolic pathway is strongly associated with the development of DN [23] .
Metabolomics in animal model research:
The studies of urine, serum, plasma and tissue metabolites of DN were also 
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Copyright: © 2015 Zhang et al. included in animal model research (rat, mice and monkey). Details of metabolites are shown in Table 6 . UA and allantoin may be used as potential markers for oxidative stress in DN by the research in mice [7] . Integrated information from serum and urine could reveal the systemic metabolic changes during the development of DN in a monkey model using 1 H NMR-based metabonomics [8] . In the rat model of DN, intrarenal metabolomics based on integrated GC-TOF MS and UPLC-TOF MS analytical platform was applied to find increasing intrarenal organic toxin including uremic toxins, glucuronides and glucotoxicity strongly associated with the progression of DN [17] .
It is important to note that the extent of changes in differential metabolites and biomarkers also play an important role in the studies. Some researchers indicated that, Maltose in model groups had 498.56 fold change compared with that in control groups [17] . Another study showed levels of 4-hydroxyphenyl acetic acid and hippuric acid is reverse correlation with the decline in renal function by contrast [16] . These conclusions have irreplaceable significance in the study of DN.
The related metabolic pathways was also well observed in the animal model research of DN. Disturbed metabolic pathways, including NAD + metabolism, purine metabolism, oxidative stress, 
